Current Drug Targets
Volume 21, 16 Issues, 2020
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Current Drug Targets, Volume 16 - Number 4
Editorial
CYLD-Mediated Signaling and Diseases
, 16(4): 284 - 294Bryan J. Mathis, Yimu Lai, Chen Qu, Joseph S. Janicki and Taixing Cui
DOI: 10.2174/1389450115666141024152421
CYLD-Mediated Signaling and Diseases
The Role of Adipocytokines in Atherogenesis and Atheroprogression
, 16(4): 295 - 320Federico Carbone, Francois Mach and Fabrizio Montecucco
DOI: 10.2174/1389450115666141109213439
The Role of Adipocytokines in Atherogenesis and Atheroprogression
Update on the Role of Neutrophils in Atherosclerotic Plaque Vulnerability
, 16(4): 321 - 333Federico Carbone, Francois Mach and Fabrizio Montecucco
DOI: 10.2174/1389450115666141110093013
Update on the Role of Neutrophils in Atherosclerotic Plaque Vulnerability
The Activated Endocannabinoid System in Atherosclerosis: Driving Force or Protective Mechanism?
, 16(4): 334 - 341Sabine Steffens and Pal Pacher
DOI: 10.2174/1389450115666141202113225
The Activated Endocannabinoid System in Atherosclerosis: Driving Force or Protective Mechanism?
Auto-Antibodies As Possible Markers and Mediators of Ischemic, Dilated, and Rhythmic Cardiopathies
, 16(4): 342 - 360Nathalie Satta and Nicolas Vuilleumier
DOI: 10.2174/1389450115666141125122416
Auto-Antibodies As Possible Markers and Mediators of Ischemic, Dilated, and Rhythmic Cardiopathies
Aquaporin-1 and Sodium-Hydrogen Exchangers as Pharmacological Targets in Diabetic Atherosclerosis
, 16(4): 361 - 365Rosalinda Madonna and Raffaele De Caterina
DOI: 10.2174/1389450116666141219115720
Aquaporin-1 and Sodium-Hydrogen Exchangers as Pharmacological Targets in Diabetic Atherosclerosis
Indoxyl Sulfate: A Candidate Target for the Prevention and Treatment of Cardiovascular Disease in Chronic Kidney Disease
, 16(4): 366 - 372Chiara Barisione, Giorgio Ghigliotti, Marco Canepa, Manrico Balbi, Claudio Brunelli and Pietro Ameri
DOI: 10.2174/1389450116666141230114500
Indoxyl Sulfate: A Candidate Target for the Prevention and Treatment of Cardiovascular Disease in Chronic Kidney Disease
Macrophages and Dendritic Cells: The Usual Suspects in Atherogenesis
, 16(4): 373 - 382Christina Kassiteridi and Claudia Monaco
DOI: 10.2174/1389450116666150330115809
Macrophages and Dendritic Cells: The Usual Suspects in Atherogenesis
MicroRNAs as Tools and Effectors for Patient Treatment in Gastrointestinal Carcinogenesis
, 16(4): 383 - 392Edoardo D'Angelo, Caterina Vicentini, Marco Agostini, Andras Kiss, Raffaele Baffa, Aldo Scarpa and Matteo Fassan
DOI: 10.2174/1389450116666141210091454
TNF Superfamily Protein-Protein Interactions: Feasibility of Small- Molecule Modulation
, 16(4): 393 - 408Yun Song and Peter Buchwald
DOI: 10.2174/1389450116666150223115628
TNF Superfamily Protein-Protein Interactions: Feasibility of Small- Molecule Modulation
Editor-in-Chief
Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.63
Advertisement
Webmaster Contact: info@benthamscience.net